Surgery Doctors in Slc, UT Accepting Medicare

4 Surgery doctors found. Showing 1 - 4

Dr. Robert G. Naylor, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1434 E. 4500 S., #200, Slc, UT 84117 Phone: 801-263-8511    Fax: 801-266-7243

Dr. John Taylor Smith, MD Surgery - Pediatric Surgery Medicare: Medicare Enrolled Practice Location: 100 Mario Capecchi Dr, 4550, Slc, UT 84113 Phone: 801-213-3900

Marion L Walker, MD Surgery - Pediatric Surgery Medicare: Not Enrolled in Medicare Practice Location: 100 N Mario Capecchi Dr, #1475, Slc, UT 84113 Phone: 801-662-5340

Mrs. Erika C Lloyd, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 1434 E. 4500 S., #200, Slc, UT 84117 Phone: 801-263-8511    Fax: 801-266-7243

News Archive

Review of psychosocial quit-smoking interventions for patients with coronary heart disease

Psychosocial interventions like counseling, telephone support and self-help materials can assist heart disease patients who are trying to give up cigarettes, but the most successful cessation treatments last a month or more, according to a new review of studies.

Researchers discover new target for repairing heart after heart attack

Billions of cardiac muscle cells are lost during a heart attack. The human heart cannot replenish these lost cells, so the default mechanism of repair is to form a cardiac scar.

ACE2 and TMPRSS2 not the only virus-receptors to mediate SARS-CoV-2 entry

However, a recent study published on the preprint server bioRxiv in November 2020 uncovers the major role played by the N-terminal domain of the SARS-CoV-2 virus in host infection. This could be of great use in measuring the usefulness of antibodies used in convalescent plasma therapy for COVID-19.

UCSD Skaggs School of Pharmacy, Janssen R&D partner to identify new therapeutic targets for Chagas disease

Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego have entered into a research collaboration with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to identify new therapeutic targets for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America.

Read more Medical News

› Verified 7 days ago